230 related articles for article (PubMed ID: 22096065)
1. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009).
Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi37-45. PubMed ID: 22096065
[TBL] [Abstract][Full Text] [Related]
2. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.
Coenen S; Ferech M; Malhotra-Kumar S; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):418-22. PubMed ID: 16735417
[TBL] [Abstract][Full Text] [Related]
3. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).
Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi47-56. PubMed ID: 22096066
[TBL] [Abstract][Full Text] [Related]
4. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).
Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi25-35. PubMed ID: 22096063
[TBL] [Abstract][Full Text] [Related]
5. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009).
Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi3-12. PubMed ID: 22096064
[TBL] [Abstract][Full Text] [Related]
6. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009).
Coenen S; Adriaenssens N; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi57-70. PubMed ID: 22096067
[TBL] [Abstract][Full Text] [Related]
7. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009).
Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi13-23. PubMed ID: 22096062
[TBL] [Abstract][Full Text] [Related]
8. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):401-7. PubMed ID: 16735414
[TBL] [Abstract][Full Text] [Related]
9. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.
Coenen S; Ferech M; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):413-7. PubMed ID: 16735416
[TBL] [Abstract][Full Text] [Related]
10. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe.
Adriaenssens N; Coenen S; Versporten A; Muller A; Vankerckhoven V; Goossens H;
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi71-77. PubMed ID: 22096068
[TBL] [Abstract][Full Text] [Related]
11. Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.
Adriaenssens N; Bruyndonckx R; Versporten A; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii30-ii36. PubMed ID: 34312653
[TBL] [Abstract][Full Text] [Related]
12. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):423-7. PubMed ID: 16735418
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations.
Elseviers MM; Ferech M; Vander Stichele RH; Goossens H;
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):115-23. PubMed ID: 16700079
[TBL] [Abstract][Full Text] [Related]
14. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe.
Ferech M; Coenen S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):408-12. PubMed ID: 16735415
[TBL] [Abstract][Full Text] [Related]
15. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.
Coenen S; Muller A; Adriaenssens N; Vankerckhoven V; Hendrickx E; Goossens H;
J Antimicrob Chemother; 2009 Jul; 64(1):200-5. PubMed ID: 19383728
[TBL] [Abstract][Full Text] [Related]
16. European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe.
Adriaenssens N; Coenen S; Muller A; Vankerckhoven V; Goossens H;
J Antimicrob Chemother; 2010 Apr; 65(4):769-74. PubMed ID: 20142264
[TBL] [Abstract][Full Text] [Related]
17. European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe.
Adriaenssens N; Coenen S; Kroes AC; Versporten A; Vankerckhoven V; Muller A; Blix HS; Goossens H;
J Antimicrob Chemother; 2011 Aug; 66(8):1897-905. PubMed ID: 21622674
[TBL] [Abstract][Full Text] [Related]
18. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002).
Vander Stichele RH; Elseviers MM; Ferech M; Blot S; Goossens H;
J Antimicrob Chemother; 2006 Jul; 58(1):159-67. PubMed ID: 16698845
[TBL] [Abstract][Full Text] [Related]
19. Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis.
Minalu G; Aerts M; Coenen S; Versporten A; Muller A; Adriaenssens N; Beutels P; Molenberghs G; Goossens H; Hens N
J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi79-87. PubMed ID: 22096069
[TBL] [Abstract][Full Text] [Related]
20. Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight.
Adriaenssens N; Coenen S; Versporten A; Goossens H
Int J Antimicrob Agents; 2013 Nov; 42(5):466-70. PubMed ID: 23993932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]